Market Currents
The FDA yesterday approved Novartis' (NVS) Flucelvax flu vaccine for use in adults aged 18 and...
-
Wednesday, November 21, 2012, 8:35 AM ETThe FDA yesterday approved Novartis' (NVS) Flucelvax flu vaccine for use in adults aged 18 and above. The vaccine is the first one for the illness that's produced using cultured animal cells rather than fertilized chicken eggs. That should allow mass production to begin faster if there's a pandemic.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
